GTCM
ORGO icon

Gyon Technologies Capital Management’s Organogenesis Holdings ORGO Stock Holding History

Gyon Technologies Capital Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-67,538
Closed -$962K – 624
2021
Q3 		$962K Sell
67,538
-7,667
-10% -$119K 0.26% 122
2021
Q2 		$1.25M Buy
+75,205
New +$1.4M 0.41% 83
2021
Q1 		– Sell
-35,453
Closed -$267K – 478
2020
Q4 		$267K Buy
+35,453
New +$168K 0.09% 266

Other funds holding ORGO

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gyon Technologies Capital Management's ORGO Position: Q4 2021 in Review

Gyon Technologies Capital Management sold out of Organogenesis Holdings (ORGO) in Q4 2021, closing a stake of 67,538 shares — an estimated $962K sold.

Gyon Technologies Capital Management first reported a position in ORGO in Q4 2020 and held it in 3 quarters. The position peaked at $1.25M in Q2 2021. 157 funds tracked by Wall St. Rank hold ORGO as of Q4 2021.

  • Gyon Technologies Capital Management reported no remaining Organogenesis Holdings position as of Q4 2021 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 67,538 Organogenesis Holdings shares in Q4 2021, an estimated $962K.
  • Gyon Technologies Capital Management first reported a position in Organogenesis Holdings in Q4 2020 and held it in 3 quarters.
  • Gyon Technologies Capital Management's Organogenesis Holdings position peaked at $1.25M in Q2 2021.
  • 157 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2021.

Based on Gyon Technologies Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.